BIOVENTURES INVESTORS
BIOVENTURES INVESTORS is a Series A, Series B and Series C+ fund in the US writing $3M–$7M checks into Healthcare, diagnostics, imaging, healthcare-it and medical-devices.
- Stages
- Series A, Series B, Series C+
- Sectors
- Healthcare, diagnostics, imaging, healthcare-it, medical-devices
- Check size
- $3M–$7M
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 1998
- Assets under management
- $145M-$150M
- Website
- bioventuresinvestors.com
Thesis
BioVentures Investors is a venture capital firm established in 1998, with a distinct focus on the medical technology (MedTech) sector. The firm aims to identify and support innovative companies that address significant unmet needs in healthcare, with the ultimate goal of improving patient outcomes and reducing healthcare costs. BioVentures Investors operates primarily in the United States. They concentrate their investments on emerging and growth-stage MedTech companies, with areas of interest including next-generation implantable and disposable devices, tools, diagnostics, imaging, and healthcare IT. The firm actively seeks opportunities that offer meaningful innovations and are strategically positioned for acquisition, focusing on companies that have mitigated development and regulatory risks. The firm manages approximately $145 million to $150 million in assets across five funds. They typically deploy check sizes ranging from $3 million to $7 million per investment deal, with a broader investment range of $5 million to $25 million, primarily investing in Series A and Series B rounds, as well as other later stages.
Common questions
Does BIOVENTURES INVESTORS invest at the Series A stage?
Yes. BIOVENTURES INVESTORS lists Series A, Series B and Series C+ among the stages it invests in.
What check size does BIOVENTURES INVESTORS write?
BIOVENTURES INVESTORS writes $3M–$7M checks.
Where does BIOVENTURES INVESTORS invest?
BIOVENTURES INVESTORS invests in the US.